Robert L. Nussbaum - 03 Jan 2017 Form 4 Insider Report for Invitae Corp

Reporting relationship: Chief Medical Officer
Issuer ticker: N/A
Reported as of: 03 Jan 2017
Net transaction value: +$2,099
SEC form: 4
Accepted by SEC: 20 Aug 2021, 19:05:28 UTC
Next SEC filing: 16 Jun 2021
Source filing: View source filing
Reporting owner signature: /s/ Thomas R. Brida, Attorney-in-Fact

Key filing fact

Robert L. Nussbaum filed Form 4 for Invitae Corp on 20 Aug 2021.

Key facts

This page summarizes Robert L. Nussbaum's Form 4 filing for Invitae Corp.
2 reported transactions and 1 derivative row are listed below.
Accepted by SEC: 20 Aug 2021, 19:05.

Change

No earlier filing in this sequence is available for direct comparison.
Current net transaction value: +$2,099.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

NVTA transaction

Common Stock

Options Exercise

Transaction value: $2,099
Shares: +1,666
Change %
Price: $1.26^*
Shares after: 1,666
Date: 03 Jan 2017
Ownership: Direct

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

NVTA transaction Derivative

Stock Option (right to buy)

Options Exercise

Transaction value: $0
Shares: -1,666
Change %: -100%
Price: $0.000000^*
Shares after: 0
Date: 03 Jan 2017
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 1,666
Exercise price: $1.26
Footnotes: F1

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 1 footnote

Footnote F1

The original option to purchase 1,666 shares of common stock fully vested on November 16, 2012.

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. to update or revoke optional consent for future visits. For more information, see our Privacy Policy .